Cargando…

Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report

BACKGROUND: Anaplastic thyroid carcinoma (ATC) is the most aggressive form of thyroid carcinoma. Lenvatinib, a multikinase inhibitor, is rarely used in preoperative settings due to adverse effects including delayed wound healing and fistula formation. Herein, we report the use of lenvatinib treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamazaki, Haruhiko, Masudo, Katsuhiko, Kanada, Sachie, Inayama, Yoshiaki, Hayashi, Hiroyuki, Fujii, Yu, Rino, Yasushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017899/ https://www.ncbi.nlm.nih.gov/pubmed/36920674 http://dx.doi.org/10.1186/s40792-023-01619-6

Ejemplares similares

Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma
por: Yamazaki, Haruhiko, et al.
Publicado: (2019)

A Case of Pneumothorax after Treatment with Lenvatinib for Anaplastic Thyroid Cancer with Lung Metastasis
por: Yamazaki, Haruhiko, et al.
Publicado: (2018)

Outcome of initial lenvatinib treatment in patients with unresectable anaplastic thyroid cancer
por: Iwasaki, Hiroyuki, et al.
Publicado: (2023)

Efficacy and tolerability of initial low-dose lenvatinib to treat differentiated thyroid cancer
por: Yamazaki, Haruhiko, et al.
Publicado: (2019)

Lenvatinib vs. palliative therapy for stage IVC anaplastic thyroid cancer
por: Iwasaki, Hiroyuki, et al.
Publicado: (2020)

Two cases of thyroid gland invasion by upper mediastinal carcinoma
por: Yamazaki, Haruhiko, et al.
Publicado: (2019)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

Invasive procedures in patients undergoing treatment with lenvatinib for thyroid cancer
por: Toda, Soji, et al.
Publicado: (2021)

Lenvatinib and selpercatinib successfully treated RET fusion gene-positive papillary thyroid carcinoma cardiac metastases: a case report
por: Toda, Soji, et al.
Publicado: (2023)

Three Cases of Anaplastic Thyroid Carcinoma Transformation and Leukocytosis during Lenvatinib Treatment
por: Iwasaki, Hiroyuki, et al.
Publicado: (2020)

Pneumatosis intestinalis associated with lenvatinib during thyroid cancer treatment: a case report
por: Toda, Soji, et al.
Publicado: (2021)

Efficacy and Safety of Lenvatinib in Anaplastic Thyroid Carcinoma: A Meta-Analysis
por: Huang, Dongmei, et al.
Publicado: (2022)

Efficacy of lenvatinib in a patient with anaplastic thyroid cancer
por: Oishi, Kazuyuki, et al.
Publicado: (2017)

Response to neoadjuvant paclitaxel predicts survival in anaplastic thyroid carcinoma
por: Yamazaki, Haruhiko, et al.
Publicado: (2022)

Rationale Efficacy and Safety Evidence of Lenvatinib and Pembrolizumab Association in Anaplastic Thyroid Carcinoma
por: Boudin, Laurys, et al.
Publicado: (2022)

Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer
por: Su, Xi, et al.
Publicado: (2020)

Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
por: Dierks, Christine, et al.
Publicado: (2021)

Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Anaplastic Thyroid Carcinoma
por: Osawa, Yoko, et al.
Publicado: (2017)

Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma
por: Onoda, Naoyoshi, et al.
Publicado: (2020)

Occult Thyroid Carcinoma without Malignant Thyroid Gland Findings during Preoperative Examination: Report of Three Cases
por: Toda, Soji, et al.
Publicado: (2020)

Chest wall resection and reconstruction using titanium micromesh covered with Marlex mesh for metastatic follicular thyroid carcinoma: a case report
por: Suganuma, Nobuyasu, et al.
Publicado: (2009)

Nephrectomy for Metastatic Kidney Tumor in Patients with Differentiated Thyroid Cancer: A Report of Two Cases
por: Yamazaki, Haruhiko, et al.
Publicado: (2018)

Low-intermediate dose of lenvatinib in anaplastic thyroid cancer is highly effective and safe
por: Barbaro, Daniele, et al.
Publicado: (2020)

A Large Substernal Goiter that Extended to Both Sides of the Thorax
por: Nakayama, Hirotaka, et al.
Publicado: (2018)

Renal dysfunction in patients with radioactive iodine-refractory thyroid cancer treated with tyrosine kinase inhibitors: A retrospective study
por: Iwasaki, Hiroyuki, et al.
Publicado: (2019)

A Case of Unresectable Papillary Thyroid Carcinoma Treated with Lenvatinib as Neoadjuvant Chemotherapy
por: Iwasaki, Hiroyuki, et al.
Publicado: (2020)

Nasogastric administration of lenvatinib solution in a mechanically ventilated patient with rapidly growing anaplastic thyroid cancer
por: Kawano, Fumiaki, et al.
Publicado: (2020)

Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis
por: Kim, Soo Young, et al.
Publicado: (2020)

The Knockdown of Nrf2 Suppressed Tumor Growth and Increased the Sensitivity to Lenvatinib in Anaplastic Thyroid Cancer
por: Gong, Zhongqin, et al.
Publicado: (2021)

Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cells
por: Kawamura, Yoshifumi, et al.
Publicado: (2021)

Augmentation of lenvatinib efficacy by topical treatment of miR-634 ointment in anaplastic thyroid cancer
por: Kishikawa, Masahiro, et al.
Publicado: (2021)

PSAT385 Single Center Experience with the Combination of Lenvatinib and Pembrolizumab for the Treatment of Anaplastic Thyroid Cancer
por: Vodopivec, Danica M, et al.
Publicado: (2022)

Non-functioning parathyroid carcinoma: a case report
por: Suganuma, Nobuyasu, et al.
Publicado: (2017)

Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012)

Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models
por: Enomoto, Keisuke, et al.
Publicado: (2021)

Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report
por: Luongo, Cristina, et al.
Publicado: (2021)

Rapid disease progression after discontinuation of lenvatinib in thyroid cancer
por: Yamazaki, Haruhiko, et al.
Publicado: (2020)

Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib: Three case reports
por: Tomonari, Tetsu, et al.
Publicado: (2020)

THU510 The Frequency Of Mutations In Advanced Thyroid Cancer In Japan: A Real Clinical Setting
por: Toda, Soji, et al.
Publicado: (2023)

Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
por: Wirth, Lori J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tcek4n26vbpt6ipkh0akpvgb7b